| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 526 |
| 1 | METHOTREXATE | 451 |
| 2 | RITUXIMAB | 427 |
| 3 | PREDNISONE | 404 |
| 4 | CYCLOPHOSPHAMIDE | 321 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 321 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 321 |
| 7 | ADALIMUMAB | 305 |
| 8 | INFLIXIMAB | 291 |
| 9 | PREDNISOLONE | 224 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BULEVIRTIDE | 1 | 0.0104 |
| 1 | BENZNIDAZOLE | 1 | 0.0098 |
| 2 | SUTIMLIMAB-JOME | 2 | 0.0062 |
| 3 | NELARABINE | 6 | 0.0062 |
| 4 | METEX | 2 | 0.0053 |
| 5 | IBRITUMOMAB TIUXETAN | 8 | 0.0053 |
| 6 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | 17 | 0.0052 |
| 7 | HALCINONIDE | 1 | 0.0052 |
| 8 | ETOPOSIDE PHOSPHATE | 8 | 0.0049 |
| 9 | AURANOFIN | 1 | 0.0049 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 754 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 553 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 466 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 453 |
| 4 | Alkylating Drug [EPC] | 344 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 222 |
| 6 | Thalidomide Analog [EPC] | 210 |
| 7 | Purine Antimetabolite [EPC] | 152 |
| 8 | Vitamin C [EPC] | 147 |
| 9 | Kinase Inhibitor [EPC] | 144 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Classical Complement Pathway Inhibitor [EPC] | 2 | 0.0062 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 46 | 0.0045 |
| 2 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 3 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 12 | 0.0030 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 54 | 0.0025 |
| 5 | Provitamin D2 Compound [EPC] | 70 | 0.0024 |
| 6 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 42 | 0.0022 |
| 8 | Selective T Cell Costimulation Blocker [EPC] | 9 | 0.0019 |
| 9 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |